Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date

Chau V, Bilusic M

Cancer Management and Research 2020, 12:7321-7330

Published Date: 17 August 2020